The Traderszone Network

Kroger — more than any of America’s supermarket chains — has taken a beating ever since Amazon announced plans to acquire Whole Foods.

It’s an unfortunate fact that more than 50% of working Americans admit to being unhappy on the job. And while some of that boils down to factors like money or work-related stress, a big part of it stems from the fact that many folks end up choosing the wrong profession. That’s why it’s important to understand not just what you want out of a job, but what you really don’t want. With that in mind, here are some of the roles your Foolish investors would avoid at all costs.

read more

Big drugmaker. High dividend yield. Promising new products. 

All three apply to AbbVie Inc. (NYSE: ABBV). They also all apply to GlaxoSmithKline plc (NYSE: GSK). But while AbbVie stock has achieved solid gains so far in 2017, GlaxoSmithKline’s share price isn’t very far above where it started out the year. Past performance doesn’t necessarily make one stock better than the other, though. Which of these big pharma stocks is the smarter pick for investors now? Here’s how AbbVie and GlaxoSmithKline compare.

read more

It’s an unfortunate fact that more than 50% of working Americans admit to being unhappy on the job. And while some of that boils down to factors like money or work-related stress, a big part of it stems from the fact that many folks end up choosing the wrong profession. That’s why it’s important to understand not just what you want out of a job, but what you really don’t want. With that in mind, here are some of the roles your Foolish investors would avoid at all costs.

read more

Big drugmaker. High dividend yield. Promising new products. 

All three apply to AbbVie Inc. (NYSE: ABBV). They also all apply to GlaxoSmithKline plc (NYSE: GSK). But while AbbVie stock has achieved solid gains so far in 2017, GlaxoSmithKline’s share price isn’t very far above where it started out the year. Past performance doesn’t necessarily make one stock better than the other, though. Which of these big pharma stocks is the smarter pick for investors now? Here’s how AbbVie and GlaxoSmithKline compare.

read more

At its core, Cameco Corporation (NYSE: CCJ) is in the mining industry, competing with companies like Rio Tinto plc (NYSE: RIO). The big difference is that Cameco exclusively mines uranium, which is used as a fuel in nuclear power plants. This makes it important to understand some dynamics that most other miners don’t face.

read more

Philip Morris International (NYSE: PM) and Verizon (NYSE: VZ) are usually considered slow-growth income plays for conservative investors. PMI is the second largest publicly traded tobacco company in the world, and Verizon is the top wireless service provider and second largest wireline service provider in the United States.

read more